Blueprint Medicines (BPMC) News Today → A new way to collect income from stocks (From DTI) (Ad) Free BPMC Stock Alerts $90.73 -1.53 (-1.66%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBlueprint Medicines (BPMC) to Release Quarterly Earnings on Thursdaymarketbeat.com - April 24 at 6:28 AMPiper Sandler Keeps Their Hold Rating on Blueprint Medicines (BPMC)markets.businessinsider.com - April 22 at 10:20 PMBlueprint Medicines Co. (NASDAQ:BPMC) Stock Position Trimmed by Raymond James & Associatesmarketbeat.com - April 22 at 4:09 AMBlueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024prnewswire.com - April 18 at 8:00 AMReadystate Asset Management LP Takes $3.69 Million Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 17 at 10:38 PMBlueprint Medicines Co. (NASDAQ:BPMC) Sees Large Drop in Short Interestmarketbeat.com - April 14 at 5:32 PMBlueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeuticsprnewswire.com - April 11 at 8:00 AMDecoding 6 Analyst Evaluations For Blueprint Medicinesmarkets.businessinsider.com - April 10 at 5:55 PMBlueprint Medicines Buy Rating: Promising BLU-222 Efficacy and Strong Financial Outlookmarkets.businessinsider.com - April 10 at 12:55 PMJMP Securities Reiterates "Market Outperform" Rating for Blueprint Medicines (NASDAQ:BPMC)marketbeat.com - April 10 at 11:26 AMPeregrine Capital Management LLC Sells 54,890 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 10 at 9:49 AMSG Americas Securities LLC Sells 28,025 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 6 at 4:15 AMBlueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - April 4 at 4:01 PMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 5,000 Sharesinsidertrades.com - April 2 at 4:14 AMBlueprint Medicines Corporation (NASDAQ:BPMC): When Will It Breakeven?finance.yahoo.com - March 29 at 8:08 AMVanguard Group Inc. Acquires 37,716 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 28 at 4:23 AMAssenagon Asset Management S.A. Acquires 260,321 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 27 at 6:49 AMJeffrey W. Albers Sells 11,033 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockinsidertrades.com - March 27 at 5:09 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Jeffrey W. Albers Sells 11,033 Sharesmarketbeat.com - March 27 at 12:15 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Sells $2,188,371.44 in Stockinsidertrades.com - March 23 at 8:44 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Jeffrey W. Albers Sells 25,073 Sharesmarketbeat.com - March 22 at 8:09 PMBlueprint Medicines executive sells stock worth over $399kinvesting.com - March 21 at 11:38 PMFirst Week of May 17th Options Trading For Blueprint Medicines (BPMC)nasdaq.com - March 21 at 11:38 PMBlueprint Medicines (NASDAQ:BPMC) Stock Price Down 3% Following Insider Sellingmarketbeat.com - March 20 at 10:35 AMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 13,734 Sharesinsidertrades.com - March 20 at 6:34 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) CFO Sells 13,734 Shares of Stockmarketbeat.com - March 19 at 7:31 PMAmerican Century Companies Inc. Has $33.70 Million Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 19 at 4:50 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) Insider Sells 621 Shares of Stockinsidertrades.com - March 16 at 10:36 AMBPMC Apr 2024 90.000 putfinance.yahoo.com - March 16 at 12:53 AMBlueprint Medicines Corp's Chief Commercial Officer Sells Company Sharesfinance.yahoo.com - March 15 at 7:53 PMBPMC Apr 2024 45.000 putfinance.yahoo.com - March 15 at 9:52 AMWellington Management Group LLP Increases Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 15 at 6:43 AMHudson Bay Capital Management LP Increases Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 14 at 7:25 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) Insider Sells 3,097 Shares of Stockinsidertrades.com - March 12 at 4:58 AML. Becker Hewes Sells 3,097 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockmarketbeat.com - March 11 at 7:33 PMPolar Capital Holdings Plc Boosts Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 11 at 1:50 PMBlueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 11 at 2:32 AMAnalysts Set Expectations for Blueprint Medicines Co.'s Q1 2024 Earnings (NASDAQ:BPMC)marketbeat.com - March 7 at 6:55 AMBlueprint Medicines Co. (NASDAQ:BPMC) Insider Christopher K. Murray Sells 621 Sharesmarketbeat.com - March 6 at 1:31 PMEquities Analysts Offer Predictions for Blueprint Medicines Co.'s FY2026 Earnings (NASDAQ:BPMC)marketbeat.com - March 6 at 8:32 AMBPMC Apr 2024 120.000 callfinance.yahoo.com - March 4 at 2:50 PMBPMC Dec 2024 115.000 callfinance.yahoo.com - March 4 at 9:50 AMBPMC Jun 2024 115.000 callfinance.yahoo.com - March 4 at 9:50 AMBPMC Mar 2024 100.000 putfinance.yahoo.com - March 3 at 10:32 PMBlueprint Medicines Co. (NASDAQ:BPMC) Insider Christopher K. Murray Sells 5,000 Sharesmarketbeat.com - March 1 at 3:41 PMBuy Rating Affirmed for Blueprint Medicines on Strong Ayvakit Clinical Performance and Promising Pipelinemarkets.businessinsider.com - February 26 at 1:25 PMBlueprint Medicines Receives Sell Rating Amidst Modest Polypharmacy Reduction and Negative Share Price Projectionsmarkets.businessinsider.com - February 26 at 1:25 PMBlueprint Medicines: Sell Rating Justified by Gavreto Divestiture and Strategic Shiftmarkets.businessinsider.com - February 26 at 8:24 AMBlueprint Medicines (NASDAQ:BPMC) Given "Buy" Rating at Needham & Company LLCmarketbeat.com - February 26 at 8:12 AMBlueprint Medicines (BPMC) Price Target Increased by 11.02% to 99.12msn.com - February 24 at 2:06 AM Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. BPMC Media Mentions By Week BPMC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼-0.050.41▲Average Medical News Sentiment BPMC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼45▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APLS News Today IONS News Today OGN News Today ELAN News Today BBIO News Today CYTK News Today JAZZ News Today MDGL News Today NUVL News Today ALPN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
